Translational Microbiome Conference 2020

Veranstaltungsdatum: 24. April 2020

Translational Microbiome Conference 2020 will be hosted on 21-24 April. It will bring together the leading microbiome companies working to successfully commercialise microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products across a range of therapeutic areas, from gut to skin and beyond.

The conference will focus on the challenges and hurdles that companies working in the microbiome space will have to recognise and navigate in order to successfully commercialise their products.

HGF Partner Craig Thomson will be hosting a panel discussion:

Getting your bugs in a row: preparing your IP for investment

Intellectual Property (IP) is only one of the things that investors look at when deciding to invest. How important is IP to investors? What questions can you expect to be asked of your IP? We will also explore what can be done in advance to make it easier to clearly and efficiently demonstrate to investors that your IP adequately underpins the business seeking investment (and how this can be done when funds are tight). The panel will consist of investors, microbiome professionals that are experienced at obtaining large and small level investments, and those that have assisted investors to review IP portfolios as part of pre-investment due diligence.